Comparison between Anjali Labtech IPO and Yashoda Healthcare IPO.
Anjali Labtech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Yashoda Healthcare IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Anjali Labtech IPO | Yashoda Healthcare IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | IIFL Capital Services Ltd. | JM Financial Ltd. |
| Registrar | ||
| Market Maker | ||
| DRHP | ||
| RHP | ||
| Final Prospectus | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Anjali Labtech IPO is up to ₹0.00 Cr whereas the issue size of the Yashoda Healthcare IPO is up to ₹0.00 Cr. The final issue price of Anjali Labtech IPO is and of Yashoda Healthcare IPO is .
| Anjali Labtech IPO | Yashoda Healthcare IPO | |
|---|---|---|
| Face Value | ||
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Anjali Labtech IPO opens on , while Yashoda Healthcare IPO opens on . The closing date of Anjali Labtech IPO and Yashoda Healthcare IPO is , and , respectively.
Anjali Labtech IPO P/E ratio is , as compared to Yashoda Healthcare IPO P/E ratio of .
| Anjali Labtech IPO | Yashoda Healthcare IPO | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Anjali Labtech Ltd.'s revenue increased by 110% and profit after tax (PAT) rose by 63% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials ()
| ||||||||||||||
| Promoter Shareholding (Pre-Issue) | ||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||
| P/E Ratio | ||||||||||||||||
| Market Cap | ||||||||||||||||
| ROE | ||||||||||||||||
| ROCE | ||||||||||||||||
| Debt/Equity | ||||||||||||||||
| EPS | ||||||||||||||||
| RoNW | ||||||||||||||||
In the Anjali Labtech IPO Retail Individual Investors (RII) are offered while in Yashoda Healthcare IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Anjali Labtech IPO and in Yashoda Healthcare IPO.
Anjali Labtech IPO subscribed in total, whereas Yashoda Healthcare IPO subscribed .
